Patients Treated With Platinum-Doublet Chemotherapy for Advanced Non–Small-Cell Lung Cancer Have Inferior Outcomes If Previously Treated With Platinum-based Chemoradiation-Reference-Cited by-同舟云学术

Patients Treated With Platinum-Doublet Chemotherapy for Advanced Non–Small-Cell Lung Cancer Have Inferior Outcomes If Previously Treated With Platinum-based Chemoradiation

Published:2013-09 Issue:5 Volume:14 Page:508-512
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Paramanathan Ashvin,Solomon Benjamin,Collins Marnie,Franco Michael,Kofoed Sarah,Francis Heather,Ball David,Mileshkin Linda

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference10 articles.

1. Comparative chemotherapeutic efficacy in non-small cell lung cancer patients with postoperative recurrence and stage IV disease;Sekine;J Thorac Oncol,2009

2. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients;Auperin;Ann Oncol,2006

3. Second-line chemotherapy in relapsing or refractory non–small-cell lung cancer: a review;Huisman;J Clin Oncol,2000

4. Re-challenge chemotherapy for relapsed non–small-cell lung cancer;Nagano;Lung Cancer,2010

5. New guidelines to evaluate the response to treatment in solid tumors;Therasse;J Natl Cancer Inst,2000

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of survival outcomes between de novo and recurrent stage IV gastric cancers: A retrospective cohort study;Precision and Future Medicine;2023-06-30

2. Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer;Translational Lung Cancer Research;2021-01

3. Survival Implications of De Novo Versus Recurrent Metastatic Non–Small Cell Lung Cancer;American Journal of Clinical Oncology;2019-03

4. Efficacy and Safety of Addition of Anti-PD1 to Chemotherapy in Treatment of Non-Small Cell Lung Cancer;Combinatorial Chemistry & High Throughput Screening;2019-02-26

5. Efficacy and safety of PD1/PDL1 blockades versus docetaxel in patients with pretreated advanced non-small-cell lung cancer: a meta-analysis;OncoTargets and Therapy;2018-12